Home/Filings/4/0001213900-21-013421
4//SEC Filing

Levin Ilan 4

Accession 0001213900-21-013421

CIK 0001835416other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 3:16 PM ET

Size

12.8 KB

Accession

0001213900-21-013421

Insider Transaction Report

Form 4
Period: 2021-02-19
Transactions
  • Purchase

    Units composed of 1 Class A ordinary share & 0.5 warrants

    2021-02-19$10.00/sh+325,000$3,250,000325,000 total(indirect: By Moringa Sponsor US L.P.)
  • Purchase

    Units composed of 1 Class A ordinary share & 0.5 warrants

    2021-03-03$10.00/sh+27,857$278,570352,857 total(indirect: By Moringa Sponsor US L.P.)
Holdings
  • Class A ordinary shares

    (indirect: By Moringa Sponsor US L.P.)
    2,875,000
Footnotes (5)
  • [F1]The Class A ordinary shares and warrants comprising the units are expected to begin separate trading on the 90th day following the date of the prospectus for the Issuer's initial public offering, unless the representative of the underwriters for that offering allows earlier separate trading, which would be publicly announced by the Issuer.
  • [F2]Moringa Sponsor US L.P. purchased, in a private placement concurrent with the initial closing under the Issuer's initial public offering, 325,000 units, at a purchase price of $10.00 per unit.
  • [F3]Moringa Sponsor US L.P. (which purchased the units and also holds the Class A ordinary shares reported herein) is a wholly-owned subsidiary of Moringa Sponsor, LP (those two entities, the "Sponsor Entities"). Mr. Ilan Levin serves as the sole director of, and is the sole equity owner of, the sole general partner of the Sponsor Entities and therefore possesses sole voting and investment authority with respect to the securities reported in this line. The limited partnership interests of Moringa Sponsor, LP are held by various individuals and entities. Mr. Levin disclaims beneficial ownership of the securities reported herein other than to the extent of his indirect pecuniary interest therein.
  • [F4]Moringa Sponsor US L.P. purchased, in a private placement concurrent with an additional closing under the Issuer's initial public offering, 27,857 units, at a purchase price of $10.00 per unit.
  • [F5]No transaction has been effected by the Reporting Persons with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Issuer

Moringa Acquisition Corp

CIK 0001835416

Entity typeother

Related Parties

1
  • filerCIK 0001849189

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 3:16 PM ET
Size
12.8 KB